Aberrant expression of cyclin E in low-risk node negative breast cancer

References

• Churman B, Roberts J. Cell cycle and cancer. J Natl Cancer Inst 1995; 87: 1499–501
   PubMedGoogle Scholar
• Sherr CJ. Cancer cell cycles. Science 1996; 274: 1672–7
   PubMed Web of Science ®Google Scholar
• Koff A, Giordano A, Desia D, Yamashita K, Harper JW, Elledge SJ, et al. Formation and activation of a cyclin E-cdk2 complex during G1 phase of the human cell cycle. Science 1992; 257: 1689–94
   PubMed Web of Science ®Google Scholar
• Ohtsubo M, Theodoras AM, Schumacher J, Roberts JM, Pagano M. Human cyclin E, a nuclear protein essential for the G1-to-S transition. Mol Cell Biol 1995; 15: 2612–24
   PubMed Web of Science ®Google Scholar
• Ohtsubo M, Roberts JM. Cyclin-dependent regulation of G1 in mammalian fibroblasts. Science 1993; 259: 1908–12
   PubMed Web of Science ®Google Scholar
• Spruck CH, Won KA, Rees SI. Deregulated cyclin E induces chromosomal instability. Nature 1999; 401: 297–300
   PubMed Web of Science ®Google Scholar
• Keyomarsi K, Pardee AB. Redundant Cyclin overexpression and gene amplification in breast cancer cells. Proc Natl Acad Sci USA 1993; 90: 1112–6
   PubMed Web of Science ®Google Scholar
• Buckley MF, Sweeney KJE, Hamilton JA, Sini RL, Manning DL, Nicholson RI, et al. Expression and amplification of cyclin genes in human breast cancer. Oncogene 1993; 8: 2127–33
   PubMed Web of Science ®Google Scholar
• Nielsen NH, Arnerlöv C, Emdin SO, Landberg G. Cyclin E overexpression, a negative prognostic factor in breast cancer with strong correlation to oestrogen receptor status. Br J Cancer 1996; 74: 874–80
   PubMed Web of Science ®Google Scholar
• Schraml P, Bucher C, Bissig H, Nocito A, Haas P, Wilber K, et al. Cyclin E overexpression and amplification in human tumors. J Pathol 2003; 3: 375–82
   Google Scholar
• Gray-Bablin J, Zalvide J, Fox MP, Knickerbocker CJ, DeCaprio JA, Keyomarsi K. Cyclin E, a redundant cyclin in breast cancer. Proc Natl Acad Sci USA 1996; 93: 15215–20
   PubMed Web of Science ®Google Scholar
• Porter D, Zang N, Danes C, McGahren M, Harwell R, Faruki S, Keyomarsi K. Tumor-specific proteolytic processing of cyclin E generates lower-molecular-weight forms. Mol Cell Biol 2001; 21: 6254–69
   PubMed Web of Science ®Google Scholar
• Strohmaier H, Spruck CH, Kaiser P, Won KA, Sangfeldt O, Reed SI. Human F-box protein hCdc4 targets cyclin E for proteolysis and is mutated in a breast cancer cell line. Nature 2001; 413: 316–22
   PubMed Web of Science ®Google Scholar
• Sieuwerts A, Look M, Meijer-van Gelder M, Timmermans M, Trapman A, Rodriguez Garcia R, et al. Which cyclin E prevails as prognostic marker for breast cancer? Results from a retrospective study involving 635 lymph node negative breast cancer patients. Clin Cancer Res 2006; 12: 3319–28
   PubMedGoogle Scholar
• Keyomarsi K, Tucker SL, Buchholtz TA, Callister M, Ding Y, Hotobagyi G, et al. Cyclin E and survival in patients with breast cancer. New Engl J Med 2002; 347: 1566–75
   PubMed Web of Science ®Google Scholar
• Scott KA, Walker RA. Lack of immunoreactivity in non-malignant breast and association with proliferation in breast cancer. Br J Cancer 1997; 76: 1288–92
   PubMed Web of Science ®Google Scholar
• Kühling H, Alm P, Olsson H, Fernö M, Baldetorp B, Parwesch R, et al. Expression of cyclins E, A and B, and prognosis in lymph node-negative breast cancer. J Pathol 2003; 199: 424–31
   PubMed Web of Science ®Google Scholar
• Lindahl T, Landberg G, Ahlgren J, Nordgren H, Norberg T, Klaar S, et al. Overexpression of cyclin E protein is associated with specific mutation types in the p53 gene and poor survival in human breast cancer. Carcinogenesis 2004; 25: 375–80
   PubMed Web of Science ®Google Scholar
• Wang L, Shao Z-M. Cyclin E expression and prognosis in breast cancer patients: A meta-analysis of published studies. Cancer Invest 2006; 24: 581–7
   PubMed Web of Science ®Google Scholar
• Erlandsson F, Wählby C, Ekholm-Reed S, Hellström A-C, Bengtsson E, Zetterberg A. Abnormal expression pattern of cyclin E in tumour cells. Int J Cancer 2003; 104: 369–75
   PubMed Web of Science ®Google Scholar
• Erlandsson F, Linnman C, Ekholm S, Bengtsson E, Zetterberg A. A detailed analysis of cyclin A accumulation et the G1/S border in normal and transformed cells. Exp Cell Res 2000; 259: 86–95
   PubMed Web of Science ®Google Scholar
• Erlandsson F, Martinsson-Ahlzén H-S, Wallin K-L, Hellström A-C, Andersson S, Zetterberg A. Parallel cyclin E and cyclin A expression in neoplastic lesions of the uterine cervix. Br J Cancer 2006; 94: 1045–50
   PubMed Web of Science ®Google Scholar
• Bukholm I, Bukholm G, Nesland J. Over-expression of cyclin A is highly associated with early relapse and reduced survival in patients with primary breast carcinomas. Int J Cancer 2001; 93: 283–7
   PubMed Web of Science ®Google Scholar